Chemokines and chemokine receptors in arthritis
- PMID: 20036936
- PMCID: PMC2917905
- DOI: 10.2741/s53
Chemokines and chemokine receptors in arthritis
Abstract
Chemokines are involved in leukocyte recruitment to inflammatory sites, such as the synovial tissue in rheumatoid arthritis (RA). There is a structural and a functional classification of chemokines. The former includes four groups: CXC, CC, C and CX3C chemokines. Chemokines may also be either inflammatory or homeostatic, however, these functions often overlap. Anti-chemokine and anti-chemokine receptor targeting may be therapeutically used in the future biological therapy of arthritis. Most data in this field have been obtained from animal models of arthritis as only very few human RA trials have been completed. However, it is very likely that various specific chemokine and chemokine receptor antagonists will be developed and administered to RA patients.
Similar articles
-
Chemokines and angiogenesis in rheumatoid arthritis.Front Biosci (Elite Ed). 2009 Jun 1;1(1):44-51. doi: 10.2741/E5. Front Biosci (Elite Ed). 2009. PMID: 19482623 Free PMC article. Review.
-
Chemokines and chemokine receptors in rheumatoid arthritis.Semin Immunol. 2003 Feb;15(1):15-21. doi: 10.1016/s1044-5323(02)00124-0. Semin Immunol. 2003. PMID: 12495637 Review.
-
Chemokines and chemokine receptors as novel therapeutic targets in rheumatoid arthritis (RA): inhibitory effects of traditional Chinese medicinal components.Cell Mol Immunol. 2004 Oct;1(5):336-42. Cell Mol Immunol. 2004. PMID: 16285892 Review.
-
New drug targets in rheumatoid arthritis: focus on chemokines.BioDrugs. 2004;18(3):181-7. doi: 10.2165/00063030-200418030-00004. BioDrugs. 2004. PMID: 15161335 Review.
-
Chemokines in rheumatoid arthritis.Springer Semin Immunopathol. 1998;20(1-2):115-32. doi: 10.1007/BF00832002. Springer Semin Immunopathol. 1998. PMID: 9836372 Review. No abstract available.
Cited by
-
Network pharmacology combined with GEO database identifying the mechanisms and molecular targets of Polygoni Cuspidati Rhizoma on Peri-implants.Sci Rep. 2022 May 17;12(1):8227. doi: 10.1038/s41598-022-12366-3. Sci Rep. 2022. PMID: 35581339 Free PMC article.
-
Directed evolution of broadly crossreactive chemokine-blocking antibodies efficacious in arthritis.Nat Commun. 2018 Apr 13;9(1):1461. doi: 10.1038/s41467-018-03687-x. Nat Commun. 2018. PMID: 29654232 Free PMC article.
-
Soluble syndecan-3 binds chemokines, reduces leukocyte migration in vitro and ameliorates disease severity in models of rheumatoid arthritis.Arthritis Res Ther. 2019 Jul 12;21(1):172. doi: 10.1186/s13075-019-1939-2. Arthritis Res Ther. 2019. PMID: 31300004 Free PMC article.
-
Shuttling Tolerogenic Dendritic Cells across the Blood-Brain Barrier In Vitro via the Introduction of De Novo C-C Chemokine Receptor 5 Expression Using Messenger RNA Electroporation.Front Immunol. 2018 Jan 23;8:1964. doi: 10.3389/fimmu.2017.01964. eCollection 2017. Front Immunol. 2018. PMID: 29403473 Free PMC article.
-
Cellular and Molecular Aspects of Bone Remodeling.Front Oral Biol. 2016;18:9-16. doi: 10.1159/000351895. Epub 2015 Nov 24. Front Oral Biol. 2016. PMID: 26599113 Free PMC article. Review.
References
-
- Koch AE. Review: angiogenesis: implications for rheumatoid arthritis. Arthritis Rheum. 1998;41:951–962. - PubMed
-
- Koch AE. Chemokines and their receptors in rheumatoid arthritis: future targets? Arthritis Rheum. 2005;52:710–721. - PubMed
-
- Paleolog EM, Fava RA. Angiogenesis in rheumatoid arthritis: implications for future therapeutic strategies. Springer Semin Immunopathol. 1998;20:73–94. - PubMed
-
- Rudolph EH, Woods JM. Chemokine expression and regulation of angiogenesis in rheumatoid arthritis. Curr PharmDes. 2005;11:613–631. - PubMed
-
- Szekanecz Z, Koch AE. Chemokines and angiogenesis. Curr Opin Rheumatol. 2001;13:202–208. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous